Acetate and bicarbonate fluctuations and acetate intolerance during dialysis. Plasma bicarbonate losses during acetate dialysis were prevented by using a combination of acetate and bicarbonate in the dialysate. In 21 patients who were treated with combination dialysate, the fall in mean blood pressure (MBP), and frequency of symptoms, and post-dialysis task performance were all similar to that observed during dialysis with acetate alone. Furthermore, dialysis performed with bicarbonate dialysate resulted in significantly smaller MBP drops, fewer symptoms, and an improved task performance compared to either an acetate or a combination dialysis. These findings indicate that the presence of acetate, rather than a bicarbonate loss, was responsible for the patients' intolerance to acetate dialysis. Patients symptomatic on acetate dialysis had a similar ultrafiltration rate, weight loss, MBP drops, and postdialysis serum acetate levels; they were similar in age and weight to symptom-free patients. Thus, the toxic effect of acetate was not related to serum acetate level. There was no difference in bicarbonate dialysis between patients with symptoms on acetate and the symptom-free patients in reference to MBP drops and task performance. This finding suggests that symptomatic patients were not simply less tolerant to the process of dialysis, but differed from symptom-free patients in their response to the presence of acetate.
was not related to serum acetate level. There was no difference in bicarbonate dialysis between patients with symptoms on acetate and the symptom-free patients in reference to MBP drops and task performance. This finding suggests that symptomatic patients were not simply less tolerant to the process of dialysis, but differed from symptom-free patients in their response to the presence of acetate. acetate to bicarbonate fast enough to replace bicarbonate losses into the dialysate. When bicarbonate dialysate replaced acetate, patients reported significantly fewer symptoms, and significant increases in the rates of ultrafiltration were tolerated [I] . Yet, it was still unclear whether or not the symptoms during acetate dialysis were related to elevated serum acetate levels or to the decreased bicarbonate concentrations. Our study was undertaken to clarify these issues. Bicarbonate losses during acetate dialysis were prevented by using a combination of acetate and bicarbonate anions in the dialysate. The patient's symptoms during combination dialysis were then compared with their symptoms during dialysis containing only acetate and during dialysis with only bicarbonate.
Methods
Twenty-three stable maintenance dialysis patients undergoing treatment from both the University of Washington Research Dialysis Unit, the Northwest Kidney Center (Seattle), and the Seattle Veterans Administration Hospital participated in the study. All dialyses for our study were performed at the University's Research Dialysis Unit after obtaining informed consent. The 14 female and 9 male patients ranged in age from 28 to 75 (Mean value = 54 + 14 SD).
Patients with a known history of cardiac or respiratory problems, or with diabetes mellitus were excluded from the study. Two patients receiving antihypertensive medication (propranolol) participated in the study, but their data were not included in this paper; thus 21 patients are included in the analyses.
Each patient was dialyzed three times: once each with 38 mEq/liter acetate (A), 35 mEq/liter bicarbonate (B), and a combination bath containing 38 mEq/liter acetate and 10 mEq/ liter bicarbonate (C). Each dialysate bath contained 3.5 mEq/ liter calcium, 140 mEq/liter sodium, and potassium was added as needed. The total chloride content was 102, 105, and 92 mEq/liter for the A, B, and C dialysates, respectively. Preliminary in vivo testing indicated that the 10 mEq/liter of bicarbonate in the combination dialysate in conjunction with the expected bicarbonate generation from acetate metabolism would produce serum bicarbonate levels similar to B dialysis. Thus, We have reported previously that patients who were symptomatic on acetate dialysis typically showed substantial reduction in serum bicarbonate during dialysis, high serum acetate levels, and large acid-base fluctuations [1] . These results suggested that the symptomatic patients were not converting the C dialysate was designed to reproduce the acetate levels of A dialysate while maintaining the serum bicarbonate at levels like those of bicarbonate dialysis.
The three types of dialyses were randomly ordered, and the patients were unaware of the type of dialysate. The patients were dialyzed for four hours on a C-Dak 1.8 m2 dialyzer (Cordis-Dow). Blood flow was maintained at 200 ml/min and dialysate flow at 500 ml/min.
Unlike the previous study [1] , it was not a goal of our present study to demonstrate differences in tolerance to rapid ultrafiltration. As a result, rates of ultrafiltration which were customary for each patient were used.
Fistula blood samples were drawn from the arterial line just before dialysis and every hour during dialysis for bicarbonate, acetate, and pH measurements. All samples were handled anaerobically and processed promptly on an IL 113 blood gas apparatus. Plasma bicarbonate was measured by titration [2] , and serum acetate was measured by the enzymatic method [3] .
The Choice Reaction Time (CRT) test was taken immediately before and after each dialysis. The CRT measures in milliseconds the time needed to make a decision about the color of a flashing panel. The CRT is widely used in the behavioral sciences to study stimulus recognition models [4] . It was included as an objective measure of the patients' ability to maintain sustained concentration, and it was hypothesized to vary with the patients' feelings of well being.' The average of 24 trials is taken at each test session to insure reliability. Patients also filled out a symptom check list after each dialysis to report episodes of nausea, vomiting, and headache. Blood pressure was measured before dialysis and approximately at 30-minute intervals throughout dialysis. Plasma bicarbonate ( Fig. 1) . Plasma bicarbonate levels during combination (C) dialysis were maintained successfully at levels similar to those seen on bicarbonate (B) dialysis. Predialysis bicarbonate levels for B dialysis were approximately 0.8 mEq/liter higher than for C dialysis. This difference could not be justified by the order of treatments and is thought to represent chance fluctuation. Bicarbonate levels for B and C were not different from each other during dialysis when adjusted for predialysis levels. As expected, bicarbonate levels on A dropped significantly in the first hour (P < 0.001), and hourly bicarbonate levels during acetate (A) dialysis were significantly lower than during B and C (all differences, P < 0.004). pH ( Fig. 2 ). Blood pH levels on B and C were significantly higher than on A at 1, 2, 3, and 4 hours (all differences, P < 0.004). The pH level measured during C dialysis was the same for B dialysis.
Results

Mean
Serum acetate (Fig. 3 ). Serum acetate levels were measured only for A and C dialyses, and they were not different at any time. The patients' postdialysis acetate levels on A were highly correlated with their postdialysis acetate levels on C (r = 0.87, P < 0.001). Postdialysis values ranged from 2.08 to 12 mEq/liter on A (Mean value = 6.34 3.10) and from 1.2 to 13.6 mEqfliter on C (Mean value = 6.63 3.13). The postdialysis acetate level was correlated negatively with the postdialysis bicarbonate on A (r = -0.75, P < 0.001), indicating that a greater acetate metabolism was associated with a greater bicarbonate genera-'From informal observation we found that the CRT is stable over a period of time for individual patients. The CRT appears to fluctuate with patients' reports of how they feel after dialysis. It is not necessarily related to events which occur during dialysis (for example, blood pressure change) unless these events produce effects which continue after dialysis (for example, nausea and a headache).
2All statistical tests between correlated groups were made with the Wilcoxon test; the Mann Whitney test was used for all independent group comparisons (51. The tests were chosen because they do not make any assumptions about the distribution of the raw scores, unlike the Student's t test [5] . Strictly speaking, the tests do not measure mean differences between groups, but means and standard deviations are reported for interpretability. All significant comparisons, however, were also significant when the Student's t distribution was assumed to underly the data.
Blood pressure, ultrafiltration rates, and weight loss Blood pressure (BP) changes among the three treatments were evaluated by comparing the predialysis blood pressure with the lowest blood pressure during the dialysis ( Table 1) . As evidence of the stability of these measures, ongoing systolic BP scores for A, B, and C dialyses were highly intercorrelated (F, average correlation = 0.82, range = 0.78 -0.86, P <0.001), as were the ongoing diastolic pressures (F = 0.69 range 0.65 -0.75, P < 0.002). The ongoing average BP was comparable among treatments, but the low BP values during A and C dialyses were significantly lower than during B (low systolic BP on A and C versus B, P < 0.01, low diastolic BP on A and C versus B, P < 0.04). Table 1 presents the predialysis and lowest Table 1 also presents the ultrafiltration rates and total weight loss. Ultrafiltration rate (UFR) was calculated as the number of kilograms of body wt lost per hour of actual ultrafiltration. The UFR was highly intercorrelated among the treatments (F = 0.80, range = 0.73 -0.84, P <0.001), and the average UFR's did not differ. As expected, weight loss followed the pattern of UFR (F = 0.77, range = 0.73 -0.80, P < 0.002). Average weight loss on C was statistically less than on B (P < 0.035), but only differed by 0.27 kilograms.
Although the mean UFR was the same and highly intercorrelated between A and B dialyses, there was a greater tolerance to high ultrafiltration rates on B dialysis than on A. Figure 4 plots the regression line of fall in MBP against UFR, separately for A, B, and C dialyses. The lines show a large expected difference in MBP drop for comparable rates of ultrafiltration during the three treatments3.
Symptoms and performance task scores The frequency of headache, nausea, and vomiting was recorded from the symptom questionnaires each patient filled out following dialysis. Table 2 presents these data for each treatment. Overall nearly twice as many symptoms were reported 3Because of the repeated measures (that is, each patient received all treatments), the conventional test of the difference between the slopes of the lines is inappropriate. When the patients were put into high and low UFR groups (median split), however, it was found that the average BP drop was greater on A and C compared to B, in the high group (P < 0.01) but not in the low group. for the A and C dialyses than were reported for B, (A = 23, C = 25 versus B = 13, P < 0.03). However, nausea accounted for nearly all of the differences.
Reaction-time scores were evaluated for each treatment by computing the difference between the post-and predialysis average scores for each patient. Thus, large positive numbers represent a substantial slowing of reaction time (measured in milliseconds) from pre-to postdialysis. Slowing of reaction time was highly intercorrelated among the treatments (F =0.71 range = 0.63 -0.77, P < 0.002). From Table 2 , average reaction time slowed significantly more following A and C dialyses than after B dialyses (A versus B, P < 0.03, C versus B, P < 0.01).
Reaction times following C dialysis were also significantly slower than after A. The method of partial correlation [61 was used to test whether or not this finding is related to the presence of both elevated acetate and bicarbonate (or pH) during the combination dialysis. Partial correlation statistically holds constant the level of one variable while assessing the relationship between two other variables. When the effects of either pH or bicarbonate were controlled in this way, the difference between A and C reaction-time scores disappeared. The partialed A and C scores, however, were both still larger than the scores on bicarbonate dialysis.
The 10 patients who reported nausea during acetate dialysis were compared to the 13 who did not report nausea (for reliability, similar symptoms scoring on C dialysis showed that 7 out of the 10 incidences of nausea were reported by those who also experienced nausea on A). It can be seen in Table 3 that these two patient groups did not differ on any of the treatments with respect to MBP changes, UFR, and weight loss. Age, body weight, and hematocrit also did not differ, There was a slight but not significant tendency for those with nausea to have higher acetate levels (P = 0.19) and only 3 of the 10 reporting nausea were males. Following A and C dialyses, patients who reported nausea experienced more of a slowing of reaction time than those not reporting nausea (Table 3) ; however, there was no difference between these groups after B dialysis.
Acetate levels and patient characteristics C
The relationships reported in this section pertain to acetate dialysis only. The results on combination dialysis, however, were the same. Acetate levels at the end of A dialysis were significantly related to body weight (r = 0.69, P < 0.002), and sex (Mean value = 7.9 0.8 females, Mean value = 3.93, 0.5 males, P < 0.01) but not to age (r = 0.12). Partial correlation [6] suggested that the relationship between sex and the acetate level was secondary to body weight; that is, the correlation between body weight and acetate level was still significant when the effects of sex were held constant (r = 0.35, P <0.05), but when acetate levels and sex were analyzed, holding body weight constant, the difference between males and females disappeared. Increasing acetate levels were associated with increased deterioration in CRT scores (r = 0.41, P < 0.025).
Acetate levels at the end of dialysis were negatively correlated with UFR (r = -0.42, P < 0.025), indicating less ultrafiltration the higher the acetate level and with weight loss (r = -0.55, P < 0.007). The acetate level did not significantly correlate with the fall in MBP (r = -0.15) nor with hematocrit (r = -0.01). We have reported previously that some patients experience hypotension, headache, nausea, and vomiting during acetate dialysis, and show postdialysis performance task decrements [1] . These symptoms were reduced significantly when the patients were dialyzed against the bicarbonate [1] . It was not clear from the study, nor from other clinical studies of acetate dialysis, whether or not the symptoms were related to acetate influx from the dialysate [7] [8] [9] or to the loss of bicarbonate also seen during acetate dialysis [1, 9] .
Discussion
The present data show that use of a combination of acetate and bicarbonate dialysate successfully prevented bicarbonate loss during dialysis and maintained the patients' blood bicarbonate at levels comparable to bicarbonate dialysis. Thus, the finding of a significantly higher incidence of symptoms and Symptomatic patients experienced nausea during acetate dialyses; asymptomatic patients had no nausea. b Defined in Table 2 .
Symptomatic group significantly different from asymptomatic group, P = 0.05. d Symptomatic group vs. asymptomatic group, P = 0.06.
Serum acetate level at end of dialysis (4 hrs). Abbreviations used are defined: CRT, Choice Reaction Time test; MBP, mean blood pressure; UFR, ultrafiltration rate; A, acetate dialysis group; B, bicarbonate dialysis group; C, combination dialysis group. larger drops in MBP on combination dialysis compared to bicarbonate dialysis clearly show that the occurrence of symptoms and hypotension was not due to bicarbonate loss. Furthermore, the similar frequency of symptoms, incidence of hypotension, postdialysis reaction times, and blood acetate levels on the combination and acetate dialyses implicate acetate in the pathogenesis of the dialysis-related problems.
Intradialytic pH fluctuations [1, 9] and blood osmolar changes [10] have also been suggested as causes of dialysis symptoms. In our study, acidosis was corrected consistently, even during acetate dialysis, and bicarbonate dialysis, despite producing a high pH level, was associated with a significantly less MBP drop, fewer symptoms, and less deterioration in reaction-time scores than acetate or combination dialysis; thus, alkalosis also did not contribute substantially to the symptoms.
Bergstrom has reported that blood osmolar changes are an important cause of hypotension during dialysis [10] . Previously, we found that changes in blood osmolarity during dialysis with our acetate dialysate were equivalent to the bicarbonate dialysate [1] . Thus, in this study the difference between acetate and bicarbonate dialyses should not be the result of osmolar changes.
The role of acetate levels in the development of symptoms is controversial with some studies reporting that symptoms and incidence of hypotension increase with rising acetate levels [7, 11] , whereas others find no relation between symptomatology and acetate levels [8, 12] . That the relationship seems to depend on other factors as well suggests that the issue has been poorly defined. Thus, when the ultrafiltrate was replaced by normal saline [9] , or 1.0 -1.6 m2 surface area dialyzers were used [8] , no relationship between acetate and hypotension was found.
Yet with large surface area dialyzers [1] or rapid weight loss [1, 7] on acetate dialysis, hypotension has been found. Further evidence for the role of ultrafiltration is found in Figure 4 . With 21 patients and 1.8 m2 dialyzers, the rate of ultrafiltration on acetate dialysis varied from 0.06 to 1,04 kg/hour. Although only five episodes of hypotension ( 100 mm Hg systolic BP) occurred, the fall in MBP tended to increase with increasing ultrafiltration on acetate dialysis, but similar ultrafiltration on bicarbonate (range = 0.0 -0.94 kg/hour) did not produce the same trend. These results suggest, among other things, that the incidence of frank hypotension is not a sensitive indicator of the effects of acetate unless UFR is held constant.
Still some studies report at least one patient with an acetate symptom free counterparts when both were dialyzed on bicarbonate suggests that there are some patient characteristics which result in acetate intolerance independent of its concentration in the blood. Prevailing notions of the effects of acetate, including a putative cardiac depressant effect [12, 13] , vasodilation l4, 15], increased cardiac oxygen demand and/or hypoxemia [16] , fail to account for patient individual difference variables which seem to make some patients especially sensitive to acetate. Future research should be directed at identifying the predictors of acetate intolerance.
